This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Hybio Pharmaceutical Co., Ltd.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: The Innovative Contributions of Youjin Chen
Introduction
Youjin Chen is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for synthesizing important compounds. With a total of 2 patents to his name, Chen's work is recognized for its potential in large-scale production and high purity of synthesized products.
Latest Patents
Chen's latest patents include a method for preparing ganirelix acetate and a method for preparing long-chain compounds. The ganirelix acetate patent discloses a method that involves replacing specific amino acids in a precursor peptide resin to synthesize ganirelix acetate. This method results in a product that is high in purity, has few impurities, and is cost-effective for large-scale production. The second patent focuses on a preparation method for long-chain compounds, which streamlines the deprotection process and allows for reactions to be conducted in low boiling point solvents. This innovation also simplifies post-processing, making it suitable for large-scale production.
Career Highlights
Youjin Chen is currently employed at Hybio Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving the efficiency and effectiveness of pharmaceutical synthesis.
Collaborations
Chen collaborates with notable colleagues, including Jiancheng Yuan and Jian Hua Liu, who contribute to his innovative projects and research initiatives.
Conclusion
Youjin Chen's contributions to pharmaceutical innovation through his patents and collaborative efforts highlight his role as a key figure in the field. His work not only enhances the efficiency of drug synthesis but also paves the way for future advancements in pharmaceutical production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile